1. Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma
   Bin Luo et al, 2020, Current Medical Science CrossRef
2. Genetic analysis of radiation-specific biomarkers in sinonasal squamous cell carcinomas
   Li Yan et al, 2016, Tumor Biology CrossRef
3. Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
   Nam Nhut Phan et al, 2018, Oncotarget CrossRef
4. Chitinase 3-Like 1, Nestin, and Testin Proteins as Novel Biomarkers of Potential Clinical Use in Colorectal Cancer: A Review
   Anna Szymańska-Chabowska et al, 2020, Health and Medicine CrossRef
5. KIF22 promotes bladder cancer progression by activating the expression of CDCA3
   Kai Li et al, 2021, International Journal of Molecular Medicine CrossRef
6. Prognostic value of CDCA3 in kidney renal papillary cell carcinoma
   Hao Li et al, 2021, Aging CrossRef
7. CT23 knockdown attenuating malignant behaviors of hepatocellular carcinoma cell is associated with upregulation of metallothionein 1
   Wanjing Ning et al, 2021, Cell Biology International CrossRef
8. Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer
   Mark N. Adams et al, 2017, Journal of Thoracic Oncology CrossRef
9. Structural investigation of CDCA3‐Cdh1 protein–protein interactions using in vitro studies and molecular dynamics simulation
   Tabassum Khair Barbhuiya et al, 2023, Protein Science CrossRef
10. Identification and Verification of Potential Ferroptosis-Related Biomarkers in Cervical Cancer
    Zhaodi Liu et al, 2024, Journal of Biomedical Nanotechnology CrossRef
11. CDCA3 exhibits a role in promoting the progression of ovarian cancer
    Shan Gong et al, 2022, Tissue and Cell CrossRef
12. Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy
    Katrina Kildey et al, 2021, Communications Biology CrossRef
13. Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis
    Lina Lin et al, 2021, Immunity, Inflammation and Disease CrossRef
14. Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer
    Katherine B. Sahin et al, 2021, Cancers CrossRef
15. Genome-wide targets identification of “core” pluripotency transcription factors with integrated features in human embryonic stem cells
    Leijie Li et al, 2016, Molecular BioSystems CrossRef
16. Systematic investigation of the prognostic value of cell division cycle-associated proteins for clear cell renal cell carcinoma patients
    Jialin Meng et al, 2020, Biomarkers in Medicine CrossRef
17. CDCA3 promotes the proliferation and migration of hypopharyngeal squamous cell carcinoma cells by activating the Akt/mTOR pathway
    Junfu Wu et al, 2023, Biotechnology and Genetic Engineering Reviews CrossRef
18. Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
    Yingkun Xu et al, 2022, BioMed Research International CrossRef
19. CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer
    Wenwei Qian et al, 2018, International Journal of Oncology CrossRef
20. Analysis of the Expression of Cell Division Cycle-Associated Genes and Its Prognostic Significance in Human Lung Carcinoma: A Review of the Literature Databases
    Chongxiang Chen et al, 2020, BioMed Research International CrossRef